Analysis of inflammatory signals in Japanese children with Crohn's disease

Pediatrics International

Volumn 55, Issue 6, 2013, Pages 753-756

  Fujitake, Yoshito ^a,b   Ohtsuka, Yoshikazu ^a   Ikuse, Tamaki ^a   Ohtani, Kiyotaka ^a   Aoyagi, Yo ^a   Fujii, Tohru ^a   Kudo, Takahiro ^a   Ishii, Masahiro ^b   Shimizu, Toshiaki ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Crohn's disease; interleukin 6; signal transducer and activator of transcription 4; Th1; Th17

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE MARKER; FEMALE; HUMAN; INTESTINE MUCOSA; JAPANESE; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SCHOOL CHILD; SIGNAL TRANSDUCTION; TH1 CELL; TH17 CELL; TH2 CELL; TRANSCRIPTION INITIATION; ASIAN CONTINENTAL ANCESTRY GROUP; IMMUNOLOGY;

ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CROHN DISEASE; CYTOKINES; FEMALE; HUMANS; MALE;

EID: 84890566212     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/ped.12159     Document Type: Article

References (17)

1. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599-603.
2. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 603-606.
3. Sun L, Nava GM, Stappenbeck TS,. Host genetic susceptibility, dysbiosis, and viral triggers in inflammatory bowel disease. Curr. Opin. Gastroenterol. 2011; 2: 321-327.
4. Asakura H, Suzuki K, Kitahora T, Morizane T,. Is there a link between food and intestinal microbes and the occurrence of Crohn's disease and ulcerative colitis? J. Gastroenterol. Hepatol. 2008; 23: 1794-1801.
5. Macdonald TT, Monteleone G,. Immunity, inflammation, and allergy in the gut. Science 2005; 307: 1920-1925.
6. Matsuoka K, Inoue N, Sato T, et al. T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Th1 mediated immunopathology in Crohn's disease. Gut 2004; 53: 1303-1308.
7. Monteleone I, Pallone F, Monteleone G,. Th17-related cytokines: new players in the control of chronic intestinal inflammation. BMC Med. 2011; 9: 122-127.
8. Ohtani K, Ohtsuka Y, Ikuse T, et al. Increased expression of GATA-3 but T-bet observed in the mucosa from children with acute phase of inflammatory bowel disease. Pediatr. Int. 2010; 52: 584-589.
9. Fuss IJ, Becker C, Yang Z, et al. Both IL-12 p70 and IL-23 are synthesized during acute Crohn's disease and are downregulated by treatment with anti-IL-12 p40 monoclonal antibody. Inflamm. Bowel Dis. 2006; 12: 9-15.
10. Fujino S, Andoh A, Bamba S, et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 2003; 52: 65-70.
11. Strober W, Fuss IJ,. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology 2011; 140: 1756-1767.
12. Mitsuyama K, Toyonaga A, Sasaki E, et al. Soluble interleukin-6 receptors in inflammatory bowel disease: relation to circulating interleukin-6. Gut 1995; 36: 45-49.
13. Yamamoto M, Yoshizaki K, Kishimoto T, Ito H,. IL-6 is required for the development of Th1 cell-mediated murine colitis. J. Immunol. 2000; 164: 4878-4882.
14. Ito H, Takazoe M, Fukuda Y, et al. A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody non-acute Crohn's disease. Gastroenterology 2004; 126: 989-996.
15. Yen D, Cheung J, Scheerens H, et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J. Clin. Invest. 2006; 116: 1310-1326.
16. Mangan PR, Harrington LE, O'Quinn DB, et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006; 441: 231-234.
17. + T helper cells. Cell 2006; 126: 1121-1133.